INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.57M
36.5K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

Page 109 of 508
← PrevNext →
20
Scott FranklinRSpouse
JPMJPMORGAN CHASE & CO
Partial sale
SELL
$1,001 – $15K
Aug 20, 2026
Sep 17, 2026
traded Aug 20, 2026
+28d
House PTR

Evidence

20
Scott FranklinRSelf
JPMJPMORGAN CHASE & CO
Partial sale
SELL$1,001 – $15KAug 20, 2026Sep 17, 2026
traded Aug 20, 2026
+28dHouse PTR

Evidence

19
BS
Boughton SoleilChief Legal Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$174K
6,236 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

18
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
300 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

18
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
200 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

17
KJ
Kenneweg JohnSVP, Sales & Product Marketing
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$216K
21.4K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

16
KL
Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$92K
2,165 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

16
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
2,650 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

16
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$74K
2,025 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

16
TS
Turner Michael S.Chief Legal Officer
HAWKHawkEye 360, Inc.
Open-market sale · 10b5-1 plan
SELL$296K
18.3K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
RR
Remer Eric RichardDirector
EVCMEverCommerce Inc.
Open-market sale
SELL$2,064
258 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
OH
Oey Peter HenryChief Financial Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$145K
50.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
800 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
40.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
RR
Remer Eric RichardDirector
EVCMEverCommerce Inc.
Open-market sale
SELL$4,266
533 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$519
18 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
JJ
Jergensen JoshuaPresident & COO
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
3,498 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

14
GB
Gage BrodieEVP & Chief Product &
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$390K
1,200 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

14
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$300K
4,947 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$114K
22.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
MD
McClymont DonaldDirector, Chief Executive Officer
INDIindie Semiconductor, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
50.0K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
TS
Turner Michael S.Chief Legal Officer
HAWKHawkEye 360, Inc.
Open-market sale · 10b5-1 plan
SELL$134K
8,250 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

13
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$114K
22.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$81K
249 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$164K
29.6K sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

11
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$87K
249 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

11
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
300 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$102K
1,600 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
HM
Hanson Scott McLeanDirector, Chief Technology Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$116K
1,953 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

11
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
1,900 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$278K
2,572 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$667K
3,901 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$371K
2,129 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$687K
3,990 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$323K
1,843 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$401K
2,319 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

9
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$293K
2,728 sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

8
IJ
Inrig JulaEVP, Head of R&D & CMO
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
400 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

8
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$685K
18.5K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence